Day 2 Speakers: Substance Abuse – Lessons learned and where are we going - Presentations | Pharmacology

Note: Some presentations contained unpublished data; therefore, several speakers have provided published manuscripts related to their talks.

	Rick Bevins, Ph.D. University of Nebraska-Lincoln Bio-behavioral factors affecting the abuse liability of nicotine
	Olivier George, Ph.D. The Scripps Research Institute Identification of novel targets for cocaine and opioid use disorders using heterogeneous stock rats
	Klaus Miczek, Ph.D. Tufts University CRF-Dopamine interactions in animal models of social stress and escalated drug abuse
	Subhash C. Pandey, Ph.D. University of Illinois at Chicago Emerging Role of Epigenetic Regulation in Alcohol Use Disorders
	Tariq Rana, Ph.D. University of California-San Diego Health Sciences Epigenetic and Epitranscriptomic Regulation of HIV infection
	Sabita Roy, Ph.D. University of Miami Microbial dysbiosis observed in Morphine tolerant animals is attenuated in germ free mice and reversed in probiotic treated WT mice
	Pietro Sanna, M.D. The Scripps Research Institute Stimulant abuse and HIV infection - animal models
	Mohan Sopori, Ph.D. Lovelace Respiratory Research Institute Interaction between HIV and cigarette smoke in the development of chronic lung diseases
	Minglei Guo, Ph.D. University of Nebraska Medical Center Role of Microglial activation in cocaine addiction (short talk)
	Guoku Hu, Ph.D. University of Nebraska Medical Center Extracellular vesicle-induced-lincRNA-Cox2 impairs microglial function in opioid users (short talk)
Visit Day 1 NeuroHIV – from bed to bench side for speaker presentations.